Prab: CSV import

2025-03-18T00:25:23Z

CSV import

← Older revision		Revision as of 00:25, 18 March 2025
Line 32:		Line 32:
	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-11T05:39:43Z

CSV import

← Older revision		Revision as of 05:39, 11 February 2025
Line 31:		Line 31:
	{{Immunology}}		{{Immunology}}
	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-22T12:16:49Z

CSV import

New page

'''Purinergic receptors''' are a class of [[G protein-coupled receptors]] and [[ligand-gated ion channels]] that are activated by the binding of purine nucleotides and nucleosides, such as [[adenosine]] and [[adenosine triphosphate]] (ATP). These receptors play a crucial role in various physiological processes, including neurotransmission, inflammation, and cardiovascular function. Purinergic receptors are divided into two families: P1 receptors, which are adenosine receptors, and P2 receptors, which respond to ATP and other nucleotides.

==Classification==
Purinergic receptors are classified into two main families based on their ligand specificity and mechanism of action:

* '''P1 Receptors''': Also known as adenosine receptors, these are activated by adenosine. P1 receptors are further divided into four subtypes: A1, A2A, A2B, and A3. Each subtype has distinct tissue distribution and physiological roles. For example, A1 receptors are involved in the inhibition of [[adenylate cyclase]] activity, leading to a decrease in [[cAMP]] levels, while A2A receptors generally act to increase cAMP levels.
* '''P2 Receptors''': These receptors are activated by ATP and other nucleotides. P2 receptors are subdivided into P2X and P2Y receptors. P2X receptors are ligand-gated ion channels, while P2Y receptors are G protein-coupled receptors. There are multiple subtypes of each, with varying functions and tissue distributions. For instance, P2X1 receptors are involved in muscle contraction, whereas P2Y12 receptors play a critical role in platelet aggregation.

==Function==
Purinergic receptors are involved in a wide range of physiological and pathological processes. In the nervous system, they contribute to neurotransmission and neuromodulation. In the immune system, activation of certain purinergic receptors can modulate immune responses and inflammation. In the cardiovascular system, these receptors influence heart rate, blood pressure, and vascular tone.

==Pathological Implications==
Dysregulation or abnormal expression of purinergic receptors has been implicated in various diseases, including [[neurodegenerative diseases]], [[cardiovascular diseases]], and [[cancer]]. For example, overexpression of P2X7 receptors has been associated with increased inflammation and has been studied as a potential therapeutic target in diseases like [[rheumatoid arthritis]] and [[depression]].

==Therapeutic Potential==
Given their wide-ranging roles in physiological and pathological processes, purinergic receptors present promising targets for therapeutic intervention. Drugs targeting adenosine receptors, such as A2A receptor antagonists, are being explored for the treatment of Parkinson's disease. Similarly, P2Y12 receptor antagonists, like clopidogrel, are already in use as antiplatelet agents in the prevention of stroke and myocardial infarction.

==Research Directions==
Research on purinergic receptors continues to uncover their complex roles in health and disease. Advances in understanding the molecular structure, signaling pathways, and physiological functions of these receptors may lead to the development of novel therapeutic agents for a variety of conditions.

[[Category:G protein-coupled receptors]]
[[Category:Ion channels]]
[[Category:Neurochemistry]]
[[Category:Cardiovascular system]]
[[Category:Immunology]]

{{G protein-coupled receptors}}
{{Ion channels}}
{{Neurochemistry}}
{{Cardiovascular system}}
{{Immunology}}
{{medicine-stub}}

Purinergic receptor - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import